| Date | Speaker | Collaborators | Project Title | Location |
| 1/6/2011 | Hartmut Jaeschke, Ph.D. | Matthew Sharpe, M.D. and Mohammad Taha, M.D. | Insight into mechanisms of acetaminophen hepatotoxicity in patients | Beller 1001-1003 |
| 1/20/2011 | Jie Liu, Ph.D. | Mojtaba Olyaee, M.D. | The role of metallothionein in liver diseases | Beller 1001-1003 |
| 2/3/2011 | Jim Luyendyk, Ph.D. | Tissue factor-dependent coagulation contributes to chronic liver disease | Beller 1001-1003 | |
| 2/17/2011 | Winston Dunn, M.D. | The interaction between NASH and alcohol in humans | Beller 1001-1003 | |
| 3/3/2011 | Benyi Li, Ph.D. | Steven Weinman, M.D./Ph.D. | Alterations of autophagy genes in HCV positive livers | Beller 1001-1003 |
| 3/17/2011 | Samuel French, M.D./Ph.D. (UCLA) | The role of the innate immune system in drug induced preneoplasia cell change in the liver | Beller 1001-1003 | |
| 3/24/2011 | Liang Xu, M.D./Ph.D. (KUMC Cancer Center) |
Molecular therapy targeting cancer and cancer stem cells | Beller 1001-1003 | |
| 4/7/2011 | Gregory Reed, Ph.D. | Richard Gilroy, M.D. and Ryan Taylor, M.D. | Prurtis in cholestatic liver disease: role of specific bile acids | Orr Major 1014 |
| 4/20/2011 | Scott Friedman, M.D. (The Mount Sinai Medical Center) |
Hepatic fibrosis and its link to HCC | Beller 1001-1003 |
Every sentence I utter must be understood not as an affirmation, but as a question.
Niels Henrik David Bohr (1885-1962) Danish physicist

